The true 28-day cost of a dog peptide protocol

What we compared

We built four cost models for a hypothetical 45 lb dog unless a row says otherwise. The models cover one 28-day window for recurring options and the first surgical episode for TPLO. They are planning estimates, not quotes. The pen price is the published product price; tax, shipping, and local disposal costs are excluded. We did not include travel, insurance, time, or the cost of treating an unrelated condition.

The 28-day comparison

Ranges are not averages. A clinic or pharmacy at the low end and one at the high end can differ by more than the price of the product. The TPLO range includes a $0–$1,559 complication allowance; the low end assumes no complication, the high end uses a published mean postoperative cost for a surgical-site infection. Every row's source URL and capture date are in the sources table below.

How the vial-stack estimate works

Pawgen publishes K9-REPAIR at $80 for one pack, $144 for two, and $256 for four. Its own listing says one pack is a four-week supply for small dogs and a two-week supply for medium and large dogs, and that BAC water is included. That is why the small-dog model uses one pack and the medium/large model uses two. We used the published two-pack price of $144; two single packs would be $160. We did not assume a dose or a weight band beyond that public statement.

The supply math is deliberately conservative. A 100-count box of U-100 insulin syringes — one common format; your protocol may use a different gauge or volume — is $21.95 at 1-800-PetMeds, or $6.15 for 28 syringes, a one-per-day upper bound. A 1.5-quart sharps container is $9.93 at Chewy; we spread one container across 100 syringes, which adds $2.78 per 28 days. Alcohol swabs are $2.39 for 200 at Target, or $0.33 for 28. The spoilage allowance is 10% of the peptide spend — a planning assumption, not a published rate.

If you buy BAC water separately, GoodRx listed 30 mL vials at $14.10–$24.95 when we checked. That would add roughly $14–$25 to the first 28-day window, not every window, because one vial can serve multiple reconstitutions. We left it at $0 in the base case because Pawgen includes it.

Librela: injection plus exam

Librela is a prescription biologic labeled for osteoarthritis pain in dogs and given by a veterinarian about once a month. Public cost guides put the injection at $90–$220 per visit, depending on the dog's weight and the clinic. CareCredit's 2025–2026 cost study puts a routine dog vet visit at $56–$129. A February 2026 CareCredit article lists a higher $75–$171 range; we used the lower, more conservative figure. Added together, the 28-day estimate is $146–$349.

That range can overstate the routine cost. Many clinics allow a technician-only injection visit after the first exam, and some bundle the injection and exam into one fee. Ask for the all-in monthly price at your dog's exact weight, and ask whether an exam is charged at every visit.

TPLO: the full episode

A planning midpoint is about $4,700: the $3,525 average procedure, $172 for imaging, $160 for a rehab evaluation, $520 for eight sessions at the $65 median, and a $353 allowance equal to 10% of the procedure. Some clinics publish all-inclusive TPLO packages that already include rehab, imaging, or rechecks. Do not add those line items to a package price without checking what it covers.

Complication rates vary by study and by dog size. A 1,519-procedure retrospective reported 11.4% overall and 3.1% major complications; a 2022 systematic review reported a 20.4% mean overall rate for TPLO. The $1,559 allowance is a cost buffer, not a prediction for your dog.

Public clinic examples show the spread: Everhart lists $5,490–$5,990 all-inclusive; VSS Austin lists $3,111–$3,450 for 61–130 lb; Bernardo Heights lists $2,600 for 40–89 lb. These are examples, not a national sample.

Methodology

We used public posted prices, public procedure-cost surveys, and published clinic ranges. We did not use private quotes, invented numbers, or customer testimonials. Every figure below is labeled with a capture date. When a source is a cost guide rather than a clinic's own price list, we say so. When a number is our assumption — the spoilage rate, the 100-syringe sharps life, the 45 lb dog — we label it as an assumption.

We did not adjust older figures for inflation. The $1,559 complication allowance comes from a 2014 study and is used as a planning allowance, not a current quote. We did not include tax, shipping, travel, pet insurance, time, or the cost of a second knee surgery. We did not compare efficacy, safety, or clinical outcomes.

Assumptions

• — The dog is 45 lb, a mid-size band for the vial model.
• — One dose per scheduled day; no missed doses. We counted one syringe per calendar day as a conservative upper bound.
• — The vial pack is used within its labeled window; no waste from a missed refill.
• — One 1.5-quart sharps container lasts 100 syringes.
• — Spoilage is 10% of peptide spend, a planning assumption.
• — The Librela exam is charged once per monthly visit; technician-only visits may cost less.
• — TPLO line items are not already bundled in an all-inclusive quote.
• — No complication, or one complication at the published mean cost.

What this does not prove

• — It does not prove that any option works, is safe, or is appropriate for your dog.
• — It does not compare efficacy. Librela is an FDA-approved drug labeled for OA pain in dogs; the pen is a research-use product.
• — It does not prove that the pen is cheaper. For a small dog, the vial model was cheaper.
• — It does not prove that TPLO is worth it. It prices a surgical episode, not an outcome.
• — It does not replace a written estimate from your vet or a quote from your pharmacy.
• — It does not include the cost of diagnosis, other medications, or long-term care.

Sources and capture dates

The Chewy price was confirmed through a public Rakuten listing that identified Chewy as the seller; Chewy's product page blocked automated fetching on the capture date. Cost-guide sources are labeled as such; they are not clinic quotes. The Everhart, VSS Austin, and Bernardo Heights figures are public clinic examples, not a national sample.